Bastide Le Confort Medical (LTS:0IP1) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0IP1 Bastide Le Confort Medical SA LTS:0IP1
71 GF Score
Price €22.95
GF Value €26.01
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bastide Le Confort Medical 3-Month Share Buyback Ratio?

Bastide Le Confort Medical LTS:0IP1 71 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates LTS:0IP1 with a GF Score™ of 71/100 and a GF Value™ of €26.01 (Modestly Undervalued). The stock has 2 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

LTS:0IP1
71GF Score
Bastide Le Confort Medical SA LTS:0IP1
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Bastide Le Confort Medical (LTS:0IP1) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Bastide Le Confort Medical and its competitors.
Is Bastide Le Confort Medical's 3-Month Share Buyback Ratio too high?
Bastide Le Confort Medical's current 3-Month Share Buyback Ratio is 0.00. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's 3-Month Share Buyback Ratio compare to MCK and COR?
Bastide Le Confort Medical's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Distribution company?
A good 3-Month Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Bastide Le Confort Medical and its competitors. Bastide Le Confort Medical's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.01, compared to a current price of €22.95 — trading 11.8% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?

Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued. The current stock price of €22.95 is trading 11.8% below its estimated GF Value™ of €26.01. GuruFocus considers Bastide Le Confort Medical to be Modestly Undervalued.

Key valuation signals for LTS:0IP1:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: €26.01 vs. price of €22.95 (11.8% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bastide Le Confort Medical Business Description

Other Exchanges BLC:France1DJ:Germany
Address 12, Avenue de la Dame, Caissargues, FRA, 30132
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score

Get the complete analysis for LTS:0IP1

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.95
Price
€26.01
GF Value